Clinical Trials · NCT00447499

Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel

Name: Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 3Lanreotide

Phase: Phase 3
Recruitment status: Completed
Sponsor: Ipsen
Enrollment: 59
Start date: Apr 2007
Locations: 13 sites, United States
Primary endpoint: The Percentage of Subjects or Their Partners That Are Competent to Self-administer Somatuline Autogel at the End of the Study, (Week 24/Early Termination), as Assessed by the Competence Questionnaire Score.

View Lanreotide compound reference